$115.85 -$2.07 (-1.8%)

04:15 PM EDT on 07/09/20

Quest Diagnostics, Inc. (NYSE:DGX)

CAPS Rating: 4 out of 5

A provider of diagnostic testing, information and services, providing insights that enable physicians and other healthcare professionals to make decisions to improve health.

Current Price $115.85 Mkt Cap $15.5B
Open $0.00 P/E Ratio 19.63
Prev. Close $115.85 Div. (Yield) $2.18 (1.9%)
Daily Range $0.00 - $0.00 Volume 327,798
52-Wk Range $73.02 - $125.00 Avg. Daily Vol. 1,455,021

Caps

How do you think NYSE:DGX will perform against the market?

Add Stock to CAPS Watchlist

All Players

573 Outperform
33 Underperform
 

All-Star Players

128 Outperform
11 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:DGX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

42asdf (< 20)
Submitted January 31, 2013

Low p/e p/b and p/s with solid profits dividends and return of equity. It has quite a bit of debt (debt to equity of .8), but still has decent cash flow. No real growth.

bclan13 (82.61)
Submitted March 20, 2013

Continue to lose share to hospital labs as hospitals become more integrated. Also a target for reimbursement rate reductions because lab services may be viewed as commodities that payers can source from the lowest bidder.

Recent Community Commentary

Read the most recent pitches from players about DGX.

Recs

0
Member Avatar ShopeAJ08 (< 20) Submitted: 6/23/2020 3:28:31 PM : Outperform Start Price: $107.54 NYSE:DGX Score: +7.18

Quest has a strong presence in laboratory diagnostics. They are a robust company relied upon by many in healthcare. It will be hard for newer companies to challenge due to their enormous size and resources.

Recs

0
Member Avatar alvinpall (93.19) Submitted: 4/30/2020 6:36:27 AM : Outperform Start Price: $113.19 NYSE:DGX Score: -5.44

Quest will be busy for the next few years testing for Covid-19. This might supersede its normal business which is also profitable. It's financials look decent as well.

Recs

0
Member Avatar TMFBigFrog (69.90) Submitted: 11/17/2018 4:25:20 PM : Outperform Start Price: $92.69 NYSE:DGX Score: +9.90

New partnership with UnitedHealth Group effective January 1, 2019 should enable continued growth

Leaderboard

Find the members with the highest scoring picks in DGX.

Score Leader

amicidelbosco

amicidelbosco (48.86) Score: +104.00

The Score Leader is the player with the highest score across all their picks in DGX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
amicidelbosco 48.86 7/9/2009 Underperform 3W $46.05 +151.56% +255.56% +104.00 0 Comment
Dividends500 58.01 2/10/2014 Outperform 5Y $44.76 +158.83% +74.86% +83.96 0 Comment
line70day < 20 2/28/2014 Outperform 1Y $46.59 +148.64% +68.90% +79.73 1 Comment
Zergum < 20 3/3/2014 Outperform 5Y $46.43 +149.53% +70.14% +79.39 0 Comment
345adf < 20 3/3/2014 Outperform 5Y $46.43 +149.53% +70.14% +79.39 0 Comment
mat05 < 20 2/27/2014 Outperform 5Y $46.56 +148.83% +70.23% +78.59 0 Comment
boknows1 87.88 2/25/2014 2/27/2020 Outperform 5Y $46.74 +147.87% +69.70% +78.17 0 Comment
kingdrawpunter 53.29 1/3/2014 Outperform NS $46.45 +149.39% +71.34% +78.05 0 Comment
cpassoit 46.63 5/22/2007 Outperform 1Y $39.47 +193.51% +117.47% +76.04 0 Comment
JohnyRay 75.45 5/25/2007 Outperform 5Y $39.36 +194.30% +119.30% +75.01 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for DGX.